T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTRI
1951
DELISTED
NutriSystem, Inc.
NTRI
| $797K | ﹤0.01% |
21,498
-114
| -0.5% | -$4.41K |
|
|
NXGN
1952
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $796K | ﹤0.01% |
39,623
-481
| -1% | -$10.2K |
|
|
INAP
1953
DELISTED
Internap Corporation
INAP
| $796K | ﹤0.01% |
63,011
-781
| -1% | -$9.66K |
|
1954
OneMain Financial
OMF
$7.51B
| $794K | ﹤0.01% |
23,610
+138
| +0.6% | +$4.83K |
|
1955
CVB Financial
CVBF
$4.08B
| $789K | ﹤0.01% |
35,365
+527
| +2% | +$12.4K |
|
1956
Natural Health Trends
NHTC
$15.4M
| $789K | ﹤0.01% |
33,896
+2,752
| +9% | +$67.4K |
|
1957
Dine Brands
DIN
$440M
| $788K | ﹤0.01% |
9,697
| – | – |
|
1958
Golub Capital BDC
GBDC
$3.48B
| $788K | ﹤0.01% |
42,882
| – | – |
|
1959
Adeia
ADEA
$3.16B
| $785K | ﹤0.01% |
199,724
+46,116
| +30% | +$196K |
|
1960
Seres Therapeutics
MCRB
$45M
| $784K | ﹤0.01% |
5,162
+7
| +0.1% | +$1.13K |
|
|
TRUE
1961
DELISTED
TrueCar
TRUE
| $783K | ﹤0.01% |
55,503
-265
| -0.5% | -$3.24K |
|
1962
Antero Resources
AR
$11.3B
| $779K | ﹤0.01% |
44,010
+732
| +2% | +$14.2K |
|
1963
United Fire Group
UFCS
$1.38B
| $779K | ﹤0.01% |
15,346
-9,074
| -37% | -$484K |
|
1964
Peabody Energy
BTU
$2.94B
| $777K | ﹤0.01% |
21,813
+141
| +0.7% | +$6.05K |
|
1965
Designer Brands
DBI
$312M
| $775K | ﹤0.01% |
22,867
+206
| +0.9% | +$6.02K |
|
|
SNBR
1966
DELISTED
Sleep Number
SNBR
| $771K | ﹤0.01% |
20,971
-9
| -0% | -$292 |
|
1967
Hallador Energy
HNRG
$730M
| $767K | ﹤0.01% |
+123,387
| New | +$779K |
|
1968
DMC Global
BOOM
$153M
| $766K | ﹤0.01% |
18,782
| – | – |
|
1969
Spectrum Brands
SPB
$2.09B
| $766K | ﹤0.01% |
10,258
-228,447
| -96% | -$19.4M |
|
1970
PetMed Express
PETS
$43.4M
| $765K | ﹤0.01% |
23,175
-80
| -0.3% | -$2.99K |
|
1971
Kulicke & Soffa
KLIC
$5.01B
| $760K | ﹤0.01% |
31,900
| – | – |
|
1972
Tronox
TROX
$958M
| $760K | ﹤0.01% |
63,636
+3,600
| +6% | +$59K |
|
1973
Lithia Motors
LAD
$8.32B
| $757K | ﹤0.01% |
9,272
-65
| -0.7% | -$5.73K |
|
|
NSA
1974
DELISTED
National Storage Affiliates Trust
NSA
| $757K | ﹤0.01% |
29,768
+16,679
| +127% | +$475K |
|
|
KEM
1975
DELISTED
KEMET Corporation
KEM
| $757K | ﹤0.01% |
40,831
+434
| +1% | +$10.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.